Hyperkalemia Quality Improvement Program (HK-QIP) Study
Clinical trial NCT06884267 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06884267
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-12-11
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.